Equillium Inc's ROI from its second quarter of 2026 to the second quarter of 2025 and 5 Year Period

Return on Investment, Quarterly Results, Trends, Rankings, Statistics

What is Equillium Inc's ROI in the second quarter of 2026?
Equillium Inc recorded a cumulative net loss of $-40 million during 12 months ending in the second quarter of 2026, resulting in a negative return on investment (ROI) of -91.13%.

Within the Healthcare sector 372 other companies had a higher return on investment. While return on investment, the total ranking has deteriorated compared to the first quarter of 2026 from 3749 to 4093.

Definition and Formula of Return on Investment

Select the Comparisons :

None ▼

Select the Ratio:

Return on Investment ROI▼

None ▼

Return on Investment ROI▼

Download as CSV

Commercial Data Licensing & OEM

Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms

API & Data Feeds

Programmatic access to normalized fundamentals & ratios.

Return On Investment	(Jun 30 2026) II. Quarter	(Mar 31 2026) I. Quarter	(Dec 31 2025) IV. Quarter	(Sep 30 2025) III. Quarter	(Jun 30 2025) II. Quarter
Y / Y Investment Change TTM	203.58 %	67.44 %	-10 %	-25.03 %	-36.92 %
Y / Y Net Income Change TTM	-	-	-	-	-
Investment (TTM) in Millions	56	60	29	32	5
Return On Investment (TTM)	-91.13 %	-131.08 %	-232.14 %	-102.62 %	-88.7 %
EQ's Overall Ranking	# 4093	# 3749	# 3811	# 3677	# 3269
Seq. Investment Change TTM	40.22 %	63.88 %	15.32 %	14.56 %	-22.66 %
Seq. Net Income Change TTM	-	-	-	-	-
Net Income (TTM) in Millions	-40	-41	-45	-17	-13

EQ Company Profile >> Back to EQ Roi Comparisons >> See Annual EQ Return On Investment

Return On Investment EQ's Ranking
Within:	No.
Industry	# 154
Sector	# 373
Overall	# 4093

Return On Investment Statistics
High	Average	Low
43.16 %	-66.21 %	-786.24 %
(Dec. 31, 2005)		(Jun 30 2019)

Financial Statements
Equillium Inc's II. Quarter Investments	$ 56 Millions	EQ's Balance sheet
Equillium Inc's II. Quarter Income	$ -5 Millions	Quarterly EQ's Income Statement
EQ's Income by Division		See EQ's Income by Division

EQ Annual Return On Investment	(Dec 31 2025) 2025	(Dec 31 2024) 2024	(Dec 31 2023) 2023	(Dec 31 2022) 2022	(Dec 31 2021) 2021
Total Investments in Millions	29	19	23	46	75
Y / Y Investment Growth	50.03 %	-15.56 %	-50.45 %	-39.46 %	-3.75 %
Net Income in Millions	-45	0	-13	-62	-39
Y / Y Net Income Growth	-	-	-	-	-
Annual Return On Investment	-156.65 %	-1.89 %	-59.08 %	-137.03 %	-51.89 %

Annual Roi Comment

Definition and Formula of Return on Investment

Other ROI Ratios
Major Pharmaceutical Preparations Industry Roi Trends and Statistics
Healthcare Sector Return On Investment Statistics
Roi Trends for overall market
EQ's Roi Ratio versus Major Pharmaceutical Preparations Industry, Healthcare Sector and total Market
Highest Ranking Return On Investment
Lowest Ranking Return On Investment
Subscribers only: Roi for EQ's Competitors
Subscribers only: Roi for Equillium Inc's Suppliers
Subscribers only: Return On Investment for EQ's Customers

Other Ratios
EQ's Roa	EQ's Inventory Turnover Ratio	EQ's Growth Rates	EQ's Dividend Statistics
	EQ's Profitability Ratios	EQ's Asset Turnover Ratio	EQ's Dividend Growth
EQ's Roe	EQ's Valuation Ratios	EQ's Financial Strength Ratios	EQ's Dividend Payout Ratio

Companies with similar Return On Investment at Jun 30 2026, within Healthcare Sector

ROI

Date modified: 2026-09-26T07:35:42+00:00

Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.